Fabry Disease Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Fabry Disease Treatment Market covers analysis by Drug Type (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00008240
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Fabry Disease Treatment Market Updates by 2031

Buy Now

MARKET INTRODUCTION

Fabry disease is one of a group of conditions known as lysosomal storage diseases. It is a rare genetic disease that can affect many parts of the body, including the kidneys, heart, and skin. The patient suffers from a lack of an alpha-galactosidase enzyme that manages to progressive organ dysfunction. Abnormal accumulation of a particular fatty matter is called globotriaosylceramide and is mainly responsible for the development of fabry diseases.

MARKET DYNAMICS

The fabry disease treatment market is anticipated to grow due to the support of government bodies for the treatment of Fabry diseases such as the Food and Drug Administration (FDA). However, lack of awareness about advancements in genetic sciences, technological limitations in a particular region of the world is restraining the market growth. Moreover, extensive R&D activities are driving the fabry disease treatment market in the forecast period.

MARKET SCOPE

The "Fabry Disease Treatment Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in fabry disease treatment market with detailed market segmentation by drug type, and geography. The fabry disease treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in fabry disease treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The fabry disease treatment market is segmented on the basis of drug type. Based on drug type the market is segmented as enzyme replacement therapy (ERT), chaperone treatment, substrate reduction therapy (SRT) and others.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in fabry disease treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fabry disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting fabry disease treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the fabry disease treatment market in these regions.


World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in fabry disease treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fabry disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting fabry disease treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the fabry disease treatment market in these regions.


MARKET PLAYERS

The report covers key developments in the in fabry disease treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in fabry disease treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in fabry disease treatment market in the global market. Below mentioned is the list of few companies engaged in the fabry disease treatment market.

The report also includes the profiles of key in fabry disease treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Amicus Therapeutics Inc.
  •  Avrobio Inc.
  •  Greenovation Biotech GmbH
  •  Idorsia Pharmaceuticals Ltd.
  •  ISU Abxis Co Ltd.
  •  JCR Pharmaceuticals Co Ltd
  •  Moderna Therapeutics Inc.
  •  Protalix Biotherapeutics Inc.
  •  Sanofi S.A.
  •  Shire Plc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Fabry Disease Treatment Market?

Fabry Disease Treatment Market is expected to grow at a CAGR of 6.8% between 2023-2031

What are the driving factors impacting the Fabry Disease Treatment Market?

Much of the treatment market for Fabry disease is propelled by several factors, including an ever-increasing incidence of the disease, new diagnostic techniques, and innovations in therapies. The enlarged demographic of senior citizens, coupled with awareness and earlier diagnosis, is fueling the growth of the market. Furthermore, both favorable reimbursement policies and increasing healthcare expenditure are working in favor of expensive treatments. In addition, a robust pipeline of therapeutic candidates under development is expected to propel the future growth of the market.

What are the future trends of the Fabry Disease Treatment Market?

Major changes are expected in the treatment market of Fabry disease in the years to come. Prominent factors influencing the treatment market are continued development of novel therapies, including gene therapy and small molecule inhibitors, which may offer more targeted and effective treatments. Advances in diagnostic techniques, particularly newborn screening, will mean earlier diagnosis and intervention. Additionally, the increasing focus on personalized medicine will drive the development of tailored treatment strategies based on individual patient characteristics. As the understanding of Fabry disease progresses and new therapies emerge, the market is poised for significant growth and transformation.

Which are the leading players operating in the Fabry Disease Treatment Market?

The leading players of the market are: Amicus Therapeutics Inc., Avrobio Inc., Greenovation Biotech GmbH, Idorsia Pharmaceuticals Ltd., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd, Moderna Therapeutics Inc., Protalix Biotherapeutics Inc., Sanofi S.A., Shire Plc.

What are the deliverable formats of the Fabry Disease Treatment Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Fabry Disease Treatment Market - By Drug Type
1.3.2 Fabry Disease Treatment Market - By Region
1.3.2.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. FABRY DISEASE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. FABRY DISEASE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. FABRY DISEASE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. FABRY DISEASE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. FABRY DISEASE TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. FABRY DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ENZYME REPLACEMENT THERAPY (ERT)
7.3.1. Overview
7.3.2. Enzyme Replacement Therapy (ERT) Market Forecast and Analysis
7.4. CHAPERONE TREATMENT
7.4.1. Overview
7.4.2. Chaperone Treatment Market Forecast and Analysis
7.5. SUBSTRATE REDUCTION THERAPY (SRT)
7.5.1. Overview
7.5.2. Substrate Reduction Therapy (SRT) Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis

8. FABRY DISEASE TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Fabry Disease Treatment Market Overview
8.1.2 North America Fabry Disease Treatment Market Forecasts and Analysis
8.1.3 North America Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.1.4 North America Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.1.4.1 United States Fabry Disease Treatment Market
8.1.4.1.1 United States Fabry Disease Treatment Market by Drug Type
8.1.4.2 Canada Fabry Disease Treatment Market
8.1.4.2.1 Canada Fabry Disease Treatment Market by Drug Type
8.1.4.3 Mexico Fabry Disease Treatment Market
8.1.4.3.1 Mexico Fabry Disease Treatment Market by Drug Type
8.2. EUROPE
8.2.1 Europe Fabry Disease Treatment Market Overview
8.2.2 Europe Fabry Disease Treatment Market Forecasts and Analysis
8.2.3 Europe Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.2.4 Europe Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Fabry Disease Treatment Market
8.2.4.1.1 Germany Fabry Disease Treatment Market by Drug Type
8.2.4.2 France Fabry Disease Treatment Market
8.2.4.2.1 France Fabry Disease Treatment Market by Drug Type
8.2.4.3 Italy Fabry Disease Treatment Market
8.2.4.3.1 Italy Fabry Disease Treatment Market by Drug Type
8.2.4.4 Spain Fabry Disease Treatment Market
8.2.4.4.1 Spain Fabry Disease Treatment Market by Drug Type
8.2.4.5 United Kingdom Fabry Disease Treatment Market
8.2.4.5.1 United Kingdom Fabry Disease Treatment Market by Drug Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Fabry Disease Treatment Market Overview
8.3.2 Asia-Pacific Fabry Disease Treatment Market Forecasts and Analysis
8.3.3 Asia-Pacific Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.3.4 Asia-Pacific Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Fabry Disease Treatment Market
8.3.4.1.1 Australia Fabry Disease Treatment Market by Drug Type
8.3.4.2 China Fabry Disease Treatment Market
8.3.4.2.1 China Fabry Disease Treatment Market by Drug Type
8.3.4.3 India Fabry Disease Treatment Market
8.3.4.3.1 India Fabry Disease Treatment Market by Drug Type
8.3.4.4 Japan Fabry Disease Treatment Market
8.3.4.4.1 Japan Fabry Disease Treatment Market by Drug Type
8.3.4.5 South Korea Fabry Disease Treatment Market
8.3.4.5.1 South Korea Fabry Disease Treatment Market by Drug Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Fabry Disease Treatment Market Overview
8.4.2 Middle East and Africa Fabry Disease Treatment Market Forecasts and Analysis
8.4.3 Middle East and Africa Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.4.4 Middle East and Africa Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Fabry Disease Treatment Market
8.4.4.1.1 South Africa Fabry Disease Treatment Market by Drug Type
8.4.4.2 Saudi Arabia Fabry Disease Treatment Market
8.4.4.2.1 Saudi Arabia Fabry Disease Treatment Market by Drug Type
8.4.4.3 U.A.E Fabry Disease Treatment Market
8.4.4.3.1 U.A.E Fabry Disease Treatment Market by Drug Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Fabry Disease Treatment Market Overview
8.5.2 South and Central America Fabry Disease Treatment Market Forecasts and Analysis
8.5.3 South and Central America Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.5.4 South and Central America Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Fabry Disease Treatment Market
8.5.4.1.1 Brazil Fabry Disease Treatment Market by Drug Type
8.5.4.2 Argentina Fabry Disease Treatment Market
8.5.4.2.1 Argentina Fabry Disease Treatment Market by Drug Type

9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

10. FABRY DISEASE TREATMENT MARKET, KEY COMPANY PROFILES
10.1. AMICUS THERAPEUTICS INC.
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. AVROBIO INC.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. GREENOVATION BIOTECH GMBH
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. IDORSIA PHARMACEUTICALS LTD.
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. ISU ABXIS CO LTD.
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. JCR PHARMACEUTICALS CO LTD
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. MODERNA THERAPEUTICS INC.
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. PROTALIX BIOTHERAPEUTICS INC.
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SANOFI S.A.
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. SHIRE PLC.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments

11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Amicus Therapeutics Inc.
2. Avrobio Inc.
3. Greenovation Biotech GmbH
4. Idorsia Pharmaceuticals Ltd.
5. ISU Abxis Co Ltd.
6. JCR Pharmaceuticals Co Ltd
7. Moderna Therapeutics Inc.
8. Protalix Biotherapeutics Inc.
9. Sanofi S.A.
10. Shire Plc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..